Show simple item record

OXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME

dc.contributor.authorBaldwin, Stephen R.en_US
dc.contributor.authorGrum, Cyril M.en_US
dc.contributor.authorBoxer, Laurence A.en_US
dc.contributor.authorSimon, Richard H.en_US
dc.contributor.authorKetai, Loren H.en_US
dc.contributor.authorDevall, Larry J.en_US
dc.date.accessioned2006-04-07T19:35:50Z
dc.date.available2006-04-07T19:35:50Z
dc.date.issued1986-01-04en_US
dc.identifier.citationBaldwin, StephenR., Grum, CyrilM., Boxer, LaurenceA., Simon, RichardH., Ketai, LorenH., Devall, LarryJ. (1986/01/04)."OXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME." The Lancet 327(8471): 11-14. <http://hdl.handle.net/2027.42/26303>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T1B-49MWNW8-1CV/2/5f1b4b20d232377c4ad8dc8c930353ceen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/26303
dc.description.abstractHydrogen peroxide levels were measured in the breath condensate of 43 patients receiving mechanical ventilation. In 16 patients the mean breath condensate peroxide level was 1[middle dot]68+/-0[middle dot]35 [mu]mol/l on the day they met diagnostic criteria for adult respiratory distress syndrome (ARDS). The peak breath condensate peroxide level in the 27 patients in whom ARDS did not develop was significantly lower (0[middle dot]34+/-0[middle dot]08 [mu]mol/l). Plasma lysozyme, a measure of in-vivo neutrophil turnover, was significantly higher in ARDS than in non-ARDS patients (9[middle dot]2+/-2[middle dot]2 U/ml v 3[middle dot]4+/-1[middle dot]1 U/ml). These findings support the hypothesis that neutrophil activation and oxidant production are involved in the pathogenesis of ARDS.en_US
dc.format.extent553108 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleOXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROMEen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Hematology/Oncology, Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationumDivision of Hematology/Oncology, Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherPulmonary and Critical Care Medicine Division, Department of Internal Medicine, United Kingdomen_US
dc.contributor.affiliationotherPulmonary and Critical Care Medicine Division, Department of Internal Medicine, United Kingdomen_US
dc.contributor.affiliationotherPulmonary and Critical Care Medicine Division, Department of Internal Medicine, United Kingdomen_US
dc.contributor.affiliationotherPulmonary and Critical Care Medicine Division, Department of Internal Medicine, United Kingdomen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/26303/1/0000388.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/S0140-6736(86)91895-7en_US
dc.identifier.sourceThe Lanceten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.